Loading organizations...
§ Private Profile · Munich, Bayern, Germany
AI decision intelligence platform providing mobile-first apps for real-time insights to global enterprises, focused on pharma.
Based in Munich, Germany, Aily Labs develops a mobile-first AI-powered decision intelligence application that integrates complex enterprise data to provide real-time predictive analytics and actionable insights. The business-to-business software-as-a-service platform enables non-technical users within large global enterprises to apply artificial intelligence across various business functions for improved operational productivity and strategic planning. Operating profitably since its inception, the company has scaled to 200 employees and currently serves over 38,000 users worldwide on Amazon Web Services following a 500 percent customer growth rate in 2024. The enterprise software provider raised a €19 million Series A funding round led by Insight Partners and has secured major corporate clients across the pharmaceutical, retail, and consumer goods sectors, including Sanofi. Aily Labs was founded in 2020 by former Novartis executives Bianca Anghelina and Sara Bisbe López.
Aily Labs has raised $100.5M across 2 funding rounds.
Aily Labs has raised $100.5M in total across 2 funding rounds.
Aily Labs has raised $100.5M across 2 funding rounds. Most recently, it raised $80.0M Series B in November 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 1, 2025 | $80M Series B | Pegah Ebrahimi | TAU Ventures | Announced |
| Aug 25, 2023 | $20.5M Series A | Insight Partners | — | Announced |
Aily Labs has raised $100.5M in total across 2 funding rounds.
Aily Labs's investors include Pegah Ebrahimi, Tau Ventures, Insight Partners.
Aily Labs is an enterprise AI company building the first-and-only AI-powered Decision Intelligence platform that connects siloed data across organizations to deliver real-time, actionable insights for every employee.[1][2][3] It serves Fortune 500 companies like Sanofi, targeting sectors such as finance, R&D, manufacturing, supply chain, quality assurance, go-to-market, and people operations through modular apps like .fin, .r&d, .m&s, .supply, .qa, .gtm, and .ppl.[1] The platform solves data overload and siloed systems by enabling proactive, cross-functional decision-making—from forecasting and capital allocation to inventory optimization and workforce management—driving ROI, compliance, and competitive advantage.[1][2] With $80 million raised in a 2025 Series B round, Aily demonstrates strong growth momentum, scaling globally from its Munich HQ and empowering non-technical users with intuitive, always-on AI.[3][6]
Founded in 2020 as Aily Labs GmbH in Munich, Germany, the company emerged from founder Bianca's firsthand experience at Novartis, where she identified the need for technology to unify siloed data and enable faster enterprise decisions.[3][5] With no initial outside investment, Aily achieved remarkable early scale by addressing decision-making "black holes" caused by fragmented systems, quickly gaining traction among iconic enterprises.[2][5] The team comprises global AI data scientists, engineers, business, and product experts, evolving from a bootstrapped innovator to a leader in Agentic AI with modular solutions tailored to enterprise pain points.[3][4]
Aily Labs rides the enterprise AI wave, capitalizing on the shift from passive data analytics to proactive Decision Intelligence amid exploding data volumes and AI adoption in Fortune 500s.[2][3] Timing is ideal as CEOs invest millions in AI but struggle with deployment and value extraction; Aily bridges this by delivering measurable business outcomes like revenue growth and cost savings through cross-silo visibility.[5][6] Market forces favoring it include rising demand for agentic AI that acts autonomously, regulatory pressures for compliant decisions, and the need for non-experts to leverage AI in real-time operations.[1][2] By influencing how enterprises like Sanofi operate, Aily accelerates AI maturity across industries, from pharma to manufacturing, fostering a ecosystem where AI drives holistic value chains rather than isolated tools.[1][7]
Aily Labs is poised for explosive growth, leveraging its $80M Series B to expand modules, enter new verticals, and deepen global penetration beyond Europe.[3][6] Trends like multimodal AI agents and real-time enterprise data fabrics will amplify its edge, enabling even more predictive, autonomous decisions amid economic pressures for efficiency.[2] Its influence may evolve from a niche disruptor to a standard for Decision Intelligence, as more firms seek P&L-impacting AI—potentially redefining how enterprises turn data into daily competitive wins, echoing its origins in solving real-world silos.[5]